1. Home
  2. SPOK vs MSLE Comparison

SPOK vs MSLE Comparison

Compare SPOK & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

SELL

Current Price

$10.83

Market Cap

218.8M

ML Signal

SELL

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

HOLD

Current Price

$6.89

Market Cap

186.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPOK
MSLE
Founded
2004
2018
Country
United States
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
218.8M
186.9M
IPO Year
2004
2007

Fundamental Metrics

Financial Performance
Metric
SPOK
MSLE
Price
$10.83
$6.89
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $24.17
AVG Volume (30 Days)
★ 114.4K
63.5K
Earning Date
10-28-2026
11-15-2026
Dividend Yield
★ 11.65%
N/A
EPS Growth
★ 2.74
N/A
EPS
★ 0.29
N/A
Revenue
★ $139,708,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$37.00
★ N/A
Revenue Growth
★ 1.49
N/A
52 Week Low
$9.95
$5.44
52 Week High
$16.45
$13.39

Technical Indicators

Market Signals
Indicator
SPOK
MSLE
Relative Strength Index (RSI) 53.25 28.07
Support Level $10.28 $6.71
Resistance Level $10.87 $10.58
Average True Range (ATR) 0.19 0.56
MACD 0.00 -0.12
Stochastic Oscillator 61.64 10.29

Price Performance

Historical Comparison
SPOK
MSLE

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: